The patients received a personalized management plan for hypoglycaemia, which included the use of glucose powder and intramuscular glucagon for refractory cases, as well as guidance on addressing pump malfunctions, which entailed seeking hospital care for glucose stabilization. The gene discussed is GCG; the disease is Hypoglycemia.